Publication | Closed Access

Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial

NutritionNeonatologyInvestigator-initiated Phase 3Infant NutritionClinical NutritionPediatricsSevere Bronchopulmonary DysplasiaChild NutritionNutritional ScienceHuman NutritionPublic HealthMedicineLow Birthweight InfantsMicronutrient SupplementationMedical Nutrition